Mr. Jim Hutchens reports

IMAGIN MEDICAL CLOSING FINANCING TO BROADEN COMMUNICATIONS PROGRAM

Imagin Medical Inc. is closing a $120,000 financing to raise funds to be used for the company's communications program. This financing will not be oversubscribed. The company is committed to continuing the development of the i/Blue Imaging System for the detection of bladder cancer and keeping its shareholders informed of its progress.

The funds raised pursuant to the financing will be specifically targeted for a communications and marketing program, allowing the company to continue to maintain its existing cash for product development and commercialization. The financing will consist of 800,000 units at a price of 15 cents per unit, each unit to be comprised of one common share and one half of one common share purchase warrant. Each whole warrant will be exercisable into one common share in the equity of the company at an exercise price of 25 cents per warrant share. The warrants expire one year from date of issuance.

About Imagin Medical Inc.

Imagin Medical is developing imaging solutions for minimally invasive surgical procedures where endoscopes are used. The company believes it will radically improve the way physicians detect cancer and view the surgical field. Imagin's initial target market is bladder cancer, a major cancer worldwide, the sixth-most prevalent in the United States, and the most costly cancer to treat due to a greater than 50-per-cent recurrence rate. The ultrasensitive imaging technology is based upon improved optical designs and advanced light sensors.

We seek Safe Harbor.